High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
Fiche publication
Date publication
mars 2021
Journal
Chinese clinical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NOEL Georges, Pr TRUC Gilles, Dr LHERMITTE Benoît, Dr BENDER Laura, Dr CEBULA Hélène
Tous les auteurs :
Bender L, Somme F, Lhermitte B, Ahle G, Boone M, Blonski M, Pouget C, Truc G, Cebula H, Noël G
Lien Pubmed
Résumé
Atypical meningioma is a variant of meningioma with a high risk of recurrence. Gross total resection is the standard of treatment, while no consensus on optimal adjuvant management has been found.
Mots clés
Atypical meningioma, Ki-67 rate, radiotherapy, recurrence factor
Référence
Chin Clin Oncol. 2021 Mar 10;: